Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study

Chemotherapy offers meaningful disease control in adolescents and young adults with irresectable symptomatic pilocytic astrocytoma, after prior treatments. However, with the improved efficacy and tolerability of targeted treatments, such as BRAF/MEK inhibitors, treatment is shifting away from traditional chemotherapy and radiotherapy. Nevertheless, chemotherapy may still represent a viable treatment option in adolescent and young adults when no actionable molecular targets are identified or when targeted therapies have failed.

Authors

Institutions

Publication Details

Journal
Journal of Neuro-Oncology
Published
2025-10-15
DOI
https://doi.org/10.1007/s11060-025-05275-8
Citations
1
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study

Johan A F Koekkoek, Anja Gijtenbeek, Martin J. van den Bent, Jacoline E. C. Bromberg et al.
1 citations
Journal of Neuro-Oncology
Glioma Diagnosis and Treatment
1.63
article

Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study

Johan A F Koekkoek, Anja Gijtenbeek, Martin J. van den Bent, Jacoline E. C. Bromberg, Walter Taal, Nathalie E. Synhaeve, Filip De Vos, Mathilde C.M. Kouwenhoven, Martinus P G Broen, Marion Smits, Lisa Berg, Antoinette Y. N. Schouten‐van Meeteren, Joyce Wilbers
article en
1 citations

Abstract

Chemotherapy offers meaningful disease control in adolescents and young adults with irresectable symptomatic pilocytic astrocytoma, after prior treatments. However, with the improved efficacy and tolerability of targeted treatments, such as BRAF/MEK inhibitors, treatment is shifting away from traditional chemotherapy and radiotherapy. Nevertheless, chemotherapy may still represent a viable treatment option in adolescent and young adults when no actionable molecular targets are identified or when targeted therapies have failed.

Journal of Neuro-OncologyVol. 176(1)
Radboud University Nijmegen (NL), Utrecht University (NL), Leiden University Medical Center (NL), Erasmus MC (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Maastricht University (NL), Medisch Centrum Haaglanden (NL), Amsterdam Neuroscience (NL), Princess Máxima Center (NL), Elisabeth-TweeSteden Ziekenhuis (NL), Erasmus MC Cancer Institute (NL), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL)
Openalex Percentile: Top 13%
Glioma Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.